Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 Years prospective observation

Scandinavian Journal of Rheumatology

Volumn 41, Issue 1, 2012, Pages 33-38

  Borowiec, A ^a   Dabrowski, R ^a   Wozniak, J ^a   Jasek, S ^a   Chwyczko, T ^a   Kowalik, I ^a   Musiej Nowakowska, E ^a   Szwed, H ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; HYPERTENSION; JUVENILE ONSET LOCALIZED SCLERODERMA; JUVENILE SYSTEMIC SCLERODERMA; LUNG ARTERY PRESSURE; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCLERODERMA; SINUS TACHYCARDIA; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; ASYMPTOMATIC DISEASES; BLOOD PRESSURE; CARDIOMEGALY; CASE-CONTROL STUDIES; CHILD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART VALVE DISEASES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; TACHYCARDIA, SINUS; YOUNG ADULT;

EID: 84856425665     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.609489     Document Type: Article

References (34)

1. Dabich L, Sullivan DB, Cassidy JT. Scleroderma in the child. J Pediatr 1974;85:770-5.
2. Cassidy JT, Petty RE. The systemic sclerodermas and related disorders. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. Philadelphia: W.B. Saunders, 2005:442-81.
3. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005;52:2873-81. (Pubitemid 41369118)
4. Luderschmidt C, Konig G, Leisner B, Scholz S, Albert EE. Circumscribed scleroderma: internal manifestations and significant correlation to HLA-DR1 and DR5. Hautarzt 1985;36:516-21. (Pubitemid 15018823)
5. Dehen L, Roujeau JC, Cosnes A, Revuz J. Internal involvement in localized scleroderma. Medicine (Baltimore) 1994;73:241-5. (Pubitemid 24317671)
6. Mayorquin FJ, McCurley TL, Levernier JE, Myers LK, Becker JA, Graham TP, et al. Progression of childhood linear scleroderma to fatal systemic sclerosis. J Rheumatol 1994;21:1955-7. (Pubitemid 24312664)
7. Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman ED. Localized scleroderma progressing to systemic disease. Case report and review of the literature. Arthritis Rheum 1993;36:410-15. (Pubitemid 23090610)
8. Martini G, Foeldvari I, Russo R, Cuttica R. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006;54:3971-8. (Pubitemid 44955901)
9. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006;33:1004-13.
10. Foeldvari I, Zhavania M, Birdi N, Cuttica RJ, de Oliveira SH, Dent PB, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology 2000; 39:556-9. (Pubitemid 30352962)
11. Bulkley BH, Ridolfi RL, Salyer WR. Myocardial lesion of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483-90.
12. Sackner MA, Heinz ER, Steinberg AJ. The heart in scleroderma. Am J Cardiol 1966;17:542-59.
13. American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum1980;23:581-90.
14. Rich S, editor. Rich S, ed. Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998, Evian, France, September 6-10,1998, cosponsored by the World Health Organization.
15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. (Pubitemid 46924065)
16. Russo RA, Katsicas MM. Clinical characteristics of children with juvenile systemic sclerosis: follow-up of 23 patients in a single tertiary center. Pediatr Rheumatol Online J 2007;1;5:6.
17. Zulian F, Martini G. Childhood systemic sclerosis. Curr Opin Rheumatol 2007;19:592-7. (Pubitemid 47530880)
18. Martini G, Vittadello F, Kasapcopur O, MagniManzoni S, Corona F, Duarte-Salazaret C, et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatology 2009;48:119-22.
19. Targa L, Cardin G, Cozzi F. Electrocardiographic disorders in diverse clinical variations of scleroderma. G Clin Med 1990;71:17-24.
20. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994;53:502-5. (Pubitemid 24256978)
21. Quartier P, Bonnet D, Fournet J-C, Bodemer C, Acar P, Ouachee-Chardin M, et al. Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol 2002;29:1767-73. (Pubitemid 34831254)
22. Martini G, Zulian F. Clinical features and outcome in juvenile systemic sclerosis (JSSc): data from the international Padua database of 153 patients. Clin Exp Rheumatol 2006;24:S57.
23. Ciurzynski M, Bienias P, Lichodziejewska B, Kurnicka K, Szewczyk A, Glinske-Wielochowska M, et al. Non-invasive diagnostics and functional evaluation of cardiac involvement in patients with systemic sclerosis. Clin Rheumatol 2008; 27:991-7.
24. Meune C, Avouac J, Wahbi, Cabanes L, Wipff J, Mouthon L, et al. Cardiac involvement in systemic sclerosis assessed by tissue- Doppler echocardiography in routine care: a controlled study of100 consecutive patients. Arthritis Rheum 2008; 58:1803-9. (Pubitemid 351847535)
25. Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. Published online 9 March 2011. doi:10.3109/03009742.2011. 553736.
26. Hesselstrand R, Wildt M, Ekmehag B, Wuttge DM, Scheja A. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol 2011;40:127-32.
27. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al. High NT-pro brain natriuretic peptide and low carbon monoxide lung diffusion capacity are independent predictors of the occurrence of pre-capillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008;58:284-91.
28. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization, J Rheumatol 2008; 35:458-65. (Pubitemid 351374421)
29. Emdin M, Marini C, Passino C. Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis. Eur Heart J 2004;6(Suppl F):F68-73. (Pubitemid 39505061)
30. de Groote P, Gressin V, Hachulla E, Carpentier P, Guillevin L, Kahan A, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008;67:31-6.
31. Wozniak J, Dabrowski R, Łuczak D, Kwiatkowska M, Musiej- Nowakowska E, Kowalik I, et al. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol 2009;36:191-6.
32. Hesselstrand R, Scheja A, Wuttge DM, Arheden H, Ugander M. Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. Scand J Rheumatol 2011;40:133-8.
33. Dimitroulas T, Giannakoulas G, Papadopoulou K, Karvounis H, Dimitroula H, Koliakos G, et al. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol 2010;37:993-9.
34. Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009;68:1878-84.